[1] Martin BI, Mirza SK, Spina N, Spiker WR, Lawrence B, Brodke DS. Trends in lumbar fusion procedure rates and associated hospital costs for degenerative spinal diseases in the United States, 2004 to 2015. Spine 2019;44:369-76.
[2] Lurie J, Tomkins-Lane C. Management of lumbar spinal stenosis. Bmj 2016;352:h6234.
[3] Du Y, Feng C. The Efficacy of Tranexamic Acid on Blood Loss from Lumbar Spinal Fusion Surgery: A Meta-Analysis of Randomized Controlled Trials. World neurosurgery 2018;119:e228-e34.
[4] Larsen TR, Huizar JF. Direct Autologous Blood Transfusion in Cardiac Tamponade: Where Safety is Not Always First. Journal of cardiovascular electrophysiology 2019.
[5] Gupta A, Kulkarni A. A retrospective analysis of massive blood transfusion and post-operative complications in patients undergoing supra-major orthopaedic oncosurgeries. Indian journal of anaesthesia 2016;60:270.
[6] Liu W, Xi Z, Gu C, Dong R, AlHelal J, Yan Z. Impact of major bleeding on the risk of acute kidney injury in patients undergoing off-pump coronary artery bypass grafting. Journal of thoracic disease 2018;10:3381.
[7] Maxwell MJ, Wilson MJ. Complications of blood transfusion. Continuing Education in Anaesthesia, Critical Care & Pain 2006;6:225-9.
[8] Sun Q, Yu X, Nie X, Gong J, Cai M. The efficacy comparison of tranexamic acid for reducing blood loss in total knee arthroplasty at different dosage time. The Journal of arthroplasty 2017;32:33-6.
[9] Shi H, Ou Y, Jiang D, Quan Z, Zhao Z, Zhu Y. Tranexamic acid reduces perioperative blood loss of posterior lumbar surgery for stenosis or spondylolisthesis: a randomized trial. Medicine 2017;96.
[10] Demos HA, Lin ZX, Barfield WR, Wilson SH, Robertson DC, Pellegrini Jr VD. Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. The Journal of arthroplasty 2017;32:2375-80.
[11] Walterscheid Z, O’Neill C, Carmouche J. Tranexamic acid in adult elective orthopaedic and complex spinal surgery: a review. Surg Rehabil 2017;1:1-4.
[12] Charles CY, Kadri O, Kadado A, Buraimoh M, Pawloski J, Bartol S, et al. Intravenous and Oral Tranexamic Acid Are Equivalent at Reducing Blood Loss in Thoracolumbar Spinal Fusion: A Prospective Randomized Trial. Spine 2019;44:755-61.
[13] Hynes M, Calder P, Scott G. The use of tranexamic acid to reduce blood loss during total knee arthroplasty. The knee 2003;10:375-7.
[14] Endres S, Heinz M, Wilke A. Efficacy of tranexamic acid in reducing blood loss in posterior lumbar spine surgery for degenerative spinal stenosis with instability: a retrospective case control study. BMC surgery 2011;11:29.
[15] Sentilhes L, Lasocki S, Ducloy-Bouthors A, Deruelle P, Dreyfus M, Perrotin F, et al. Tranexamic acid for the prevention and treatment of postpartum haemorrhage. British journal of anaesthesia 2015;114:576-87.
[16] Morsi E, Gamal O, Drwish E. Intra-Articular versus Intravenous Tranexamic Acid in Controlling Blood Loss during Primary Total Knee Replacement. J Orthop Clin Stu Adv Res 2017;1.
[17] May JH, Rieser GR, Williams CG, Markert RJ, Bauman RD, Lawless MW. The assessment of blood loss during total knee arthroplasty when comparing intravenous vs intracapsular administration of tranexamic acid. The Journal of arthroplasty 2016;31:2452-7.
[18] Aguilera X, Martínez-Zapata MJ, Hinarejos P, Jordán M, Leal J, González J, et al. Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Archives of orthopaedic and trauma surgery 2015;135:1017-25.
[19] Lin S-Y, Chen C-H, Fu Y-C, Huang P-J, Chang J-K, Huang H-T. The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty. The Journal of arthroplasty 2015;30:776-80.
[20] Nielsen CS, Jans Ø, Ørsnes T, Foss NB, Troelsen A, Husted H. Combined intra-articular and intravenous tranexamic acid reduces blood loss in total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. JBJS 2016;98:835-41.
[21] Jia J. Combined use of intravenous and topical tranexamic acid in patients aged over 70 years old undergoing total hip arthroplasty. Journal of orthopaedic surgery and research 2019;14:1-7.
[22] Gao F-Q, Li Z-J, Zhang K, Sun W, Zhang H. Four methods for calculating blood-loss after total knee arthroplasty. Chinese medical journal 2015;128:2856.
[23] Molloy D, Archbold H, Ogonda L, McConway J, Wilson R, Beverland D. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. The Journal of bone and joint surgery British volume 2007;89:306-9.
[24] Sehat K, Evans R, Newman J. How much blood is really lost in total knee arthroplasty?: correct blood loss management should take hidden loss into account. The Knee 2000;7:151-5.
[25] Xie J, Ma J, Yue C, Kang P, Pei F. Combined use of intravenous and topical tranexamic acid following cementless total hip arthroplasty: a randomised clinical trial. Hip International 2016;26:36-42.
[26] Wu Y-g, Zeng Y, Yang T-m, Si H-b, Cao F, Shen B. The efficacy and safety of combination of intravenous and topical tranexamic acid in revision hip arthroplasty: a randomized, controlled trial. The Journal of arthroplasty 2016;31:2548-53.
[27] Zhang MP, Li MJ, Wang MX. Combined versus single application of tranexamic acid in total knee and hip arthroplasty: a meta-analysis of randomized controlled trials. International Journal of Surgery 2017;43:171-80.
[28] Ozolina A, Nemme J, Ozolins A, Bjertnæs LJ, Vanags I, Gardovskis J, et al. Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study. Frontiers in medicine 2018;5:253.
[29] Rajesparan K, Biant L, Ahmad M, Field R. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. The Journal of bone and joint surgery British volume 2009;91:776-83.
[30] Head T, Daunert S, Goldschmidt-Clermont PJ. The aging risk and atherosclerosis: a fresh look at arterial homeostasis. Frontiers in genetics 2017;8:216.
[31] Moore EE, Moore HB, Gonzalez E, Sauaia A, Banerjee A, Silliman CC. Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient. Transfusion 2016;56:S110-S4.